Spirit Capital Partners

Phase Focus develops Virtual Lens, a technology that generates high definition images of an object without the need for high quality lenses.

Structure Vision provides technology and consulting solutions for industries involved in developing particulate materials.

Asterion develops patient-friendly drugs for the treatment of serious chronic and acute disorders.

CellTran is a biotechnology company engaged in the development of cell therapy products for the wound management industry.